126
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evaluation of Nanopore Sequencing for Diagnosing Pulmonary Tuberculosis Using Negative Smear Clinical Specimens

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 673-682 | Received 24 Oct 2023, Accepted 13 Feb 2024, Published online: 18 Feb 2024

References

  • World Health Organization. Global Tuberculosis Report 2023. World Health Organization; 2023.
  • Zheng H, Zhong F, Yu G, Shen Y. Comparison of the diagnostic efficacy of the CapitalBio Mycobacterium real-time polymerase chain reaction detection test and Xpert MTB/RIF in smear-negative pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis. 2021;40(5):969–977. doi:10.1007/s10096-020-04113-1
  • Shen Y, Fang L, Xu X, Ye B, Yu G. CapitalBio Mycobacterium real-time polymerase chain reaction detection test: rapid diagnosis of Mycobacterium tuberculosis and nontuberculous mycobacterial infection. Int J Infect Dis. 2020;98:1–5. doi:10.1016/j.ijid.2020.06.042
  • Qiu X, Zheng S, Yang J, Yu G, Ye Y. Comparing mycobacterium tuberculosis RNA accuracy in various respiratory specimens for the rapid diagnosis of pulmonary tuberculosis. Infect Drug Resist. 2022;15:4195–4202. doi:10.2147/IDR.S374826
  • Elbrolosy AM, El Helbawy RH, Mansour OM, Latif RA. Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis. BMC Microbiol. 2021;21(1):144. doi:10.1186/s12866-021-02210-5
  • Rasheed W, Qureshi R, Jabeen N, Shah HA, Naseem Khan R. Diagnostic accuracy of high-resolution computed tomography of chest in diagnosing sputum smear positive and sputum smear negative pulmonary tuberculosis. Cureus. 2020;12(6):e8467. doi:10.7759/cureus.8467
  • Yu G, Wang L, Shen Y, et al. Comparison of the diagnostic accuracy of xpert MTB/RIF and CapitalBio Mycobacterium RT-PCR detection assay for tuberculous pericarditis. Infect Drug Resist. 2022;15:2127–2135. doi:10.2147/IDR.S360064
  • Bohlbro AS, Mendes AM, Sifna A, Gomes V, Rudolf F, Wejse C. Incidence of pulmonary tuberculosis in suburban Bissau, Guinea-Bissau between 2004 and 2020: a prospective cohort study. Infection. 2022;51(4):955–966. doi:10.1007/s15010-022-01958-w
  • Wu Z, Shi J, Zhou Y, et al. The diagnostic value of the thermostatic amplification of ribonucleic acid in bronchoalveolar lavage fluid in smear-negative pulmonary tuberculosis. Front Public Health. 2022;10:830477. doi:10.3389/fpubh.2022.830477
  • Yu G, Zhong F, Zhao W, Ye B, Xu K, Chen G. Head-to-head comparison of the diagnostic value of five tests for constrictive tuberculous pericarditis: five tests for constrictive TBP. Int J Infect Dis. 2022;120:25–32. doi:10.1016/j.ijid.2022.04.018
  • Yu G, Shen Y, Ye B, Shi Y. Diagnostic accuracy of Mycobacterium tuberculosis cell-free DNA for tuberculosis: a systematic review and meta-analysis. PLoS One. 2021;16:6.
  • Shen Y, Fang L, Ye B, Xu X, Yu G, Zhou L. The role of core needle biopsy pathology combined with molecular tests in the diagnosis of lymph node tuberculosis. Infect Drug Resist. 2022;15:335–345. doi:10.2147/IDR.S350570
  • Yu G, Wang X, Zhu P, Shen Y, Zhao W, Zhou L. Comparison of the efficacy of metagenomic next-generation sequencing and Xpert MTB/RIF in the diagnosis of tuberculous meningitis. J Microbiol Methods. 2021;180:106124. doi:10.1016/j.mimet.2020.106124
  • Zhou Y, Shi W, Wen Y, Mao E, Ni T. Comparison of pathogen detection consistency between metagenomic next-generation sequencing and blood culture in patients with suspected bloodstream infection. Sci Rep. 2023;13(1):9460. doi:10.1038/s41598-023-36681-5
  • Jin Y, Hu S, Feng J, Ni J. Clinical value of metagenomic next-generation sequencing using spinal tissue in the rapid diagnosis of spinal tuberculosis. Infect Drug Resist. 2023;16:3305–3313. doi:10.2147/IDR.S410914
  • Dippenaar A, Goossens SN, Grobbelaar M, et al. Nanopore sequencing for mycobacterium tuberculosis: a critical review of the literature, new developments, and future opportunities. J Clin Microbiol. 2022;60(1):e0064621. doi:10.1128/JCM.00646-21
  • Luo W, He Y, Xu J, et al. Comparison of third-generation sequencing technology and traditional microbiological detection in pathogen diagnosis of lower respiratory tract infection. Discov Med. 2023;35(176):332–342. doi:10.24976/Discov.Med.202335176.34
  • Liu Z, Yang Y, Wang Q, Wang L, Nie W, Chu N. Diagnostic value of a nanopore sequencing assay of bronchoalveolar lavage fluid in pulmonary tuberculosis. BMC Pulm Med. 2023;23(1):77. doi:10.1186/s12890-023-02337-3
  • Yu G, Shen Y, Zhong F, et al. Diagnostic accuracy of nanopore sequencing using respiratory specimens in the diagnosis of pulmonary tuberculosis. Int J Infect Dis. 2022;122:237–243. doi:10.1016/j.ijid.2022.06.001
  • Yang J, Ye W, Zhang C, et al. Accuracy of nanopore sequencing as a diagnostic assay for pulmonary tuberculosis versus smear, culture and xpert MTB/RIF: a head-to-head comparison. Trop Med Infect Dis. 2023;8(9). doi:10.3390/tropicalmed8090441
  • Zou X, Zhu Y, Qin Y, et al. Value analysis of next-generation sequencing combined with Xpert in early precise diagnosis of pulmonary tuberculosis. Diagn Microbiol Infect Dis. 2023;107(1):115921. doi:10.1016/j.diagmicrobio.2023.115921
  • Bhat J, Selvakumar N, Rao VG, Gopi PG, Yadav R, Wares DF. Yield of culture of Mycobacterium tuberculosis complex in sputum samples transported from tribal areas. Int J Tuberc Lung Dis. 2011;15(4):478–482. doi:10.5588/ijtld.10.0234
  • Green MR, Sambrook J. Touchdown Polymerase Chain Reaction (PCR). Cold Spring Harb Protoc. 2018;2018:5.
  • Li H, Birol I. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics. 2018;34(18):3094–3100. doi:10.1093/bioinformatics/bty191
  • Marais BJ, Gie RP, Schaaf HS, et al. The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004;8(3):278–285.
  • Hasen Badeso M, Sani Kalil F, Mohammed Ahmed Y, Abdulkadir Godie S, Habtamu Regesu A. Trends of tuberculosis disease from 2013–2018 in Bale Zone, Oromia Region, Ethiopia. Retrospective Review. Infect Drug Resist. 2022;15:6723–6730.
  • Petnak T, Eksombatchai D, Chesdachai S, et al. Diagnostic accuracy of interferon-gamma release assays for diagnosis of smear-negative pulmonary tuberculosis: a systematic review and meta-analysis. BMC Pulm Med. 2022;22(1):219. doi:10.1186/s12890-022-02013-y
  • Buckwalter SP, Connelly BJ, Louison LK, et al. Description, validation, and review of a decade of experience with a laboratory-developed PCR test for detection of Mycobacterium tuberculosis complex in pulmonary and extrapulmonary specimens. J Clin Tuberc Other Mycobact Dis. 2022;29:100340. doi:10.1016/j.jctube.2022.100340
  • Wang G, Wang S, Jiang G, et al. Xpert MTB/RIF Ultra improved the diagnosis of paucibacillary tuberculosis: a prospective cohort study. J Infect. 2019;78(4):311–316. doi:10.1016/j.jinf.2019.02.010
  • Yu G, Zhong F, Ye B, Xu X, Chen D, Shen Y. Diagnostic accuracy of the xpert MTB/RIF assay for lymph node tuberculosis: a systematic review and meta-analysis. Biomed Res Int. 2019;2019:4878240. doi:10.1155/2019/4878240
  • Chien JY, Lin CK, Yu J, Hsueh PR. Usefulness of xpert MTB/RIF ultra to rapidly diagnose sputum smear-negative pulmonary tuberculosis using bronchial washing fluid. Front Microbiol. 2020;11:588963. doi:10.3389/fmicb.2020.588963
  • Sun X, Song J, Leng X, et al. A preliminary evaluation of targeted nanopore sequencing technology for the detection of Mycobacterium tuberculosis in bronchoalveolar lavage fluid specimens. Front Cell Infect Microbiol. 2023;13:1107990. doi:10.3389/fcimb.2023.1107990
  • Liu Y, Ren W, Xue Z, et al. Real-time recombinase-aided amplification assay for rapid amplification of the IS1081 gene of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis. 2023;42(8):963–972. doi:10.1007/s10096-023-04626-5
  • Lodha L, Mudliar SR, Singh J, et al. Diagnostic performance of multiplex PCR for detection of mycobacterium tuberculosis complex in presumptive pulmonary tuberculosis patients and its utility in smear negative specimens. J Lab Physicians. 2022;14(4):403–411. doi:10.1055/s-0042-1757231
  • Zhao X, Ge Y, Zhang Y, et al. Pathogen diagnosis value of nanopore sequencing in severe hospital-acquired pneumonia patients. Infect Drug Resist. 2023;16:3293–3303. doi:10.2147/IDR.S410593
  • Nilgiriwala K, Rabodoarivelo MS, Hall MB, et al. Genomic sequencing from sputum for tuberculosis disease diagnosis, lineage determination, and drug susceptibility prediction. J Clin Microbiol. 2023;61(3):e0157822. doi:10.1128/jcm.01578-22
  • Wang HY, Kim H, Kim S, Kim DK, Cho SN, Lee H. Performance of a real-time PCR assay for the rapid identification of Mycobacterium species. J Microbiol. 2015;53(1):38–46. doi:10.1007/s12275-015-4495-8
  • Fu Y, Chen Q, Xiong M, et al. Clinical performance of nanopore targeted sequencing for diagnosing infectious diseases. Microbiol Spectr. 2022;10(2):e0027022. doi:10.1128/spectrum.00270-22
  • Ong CS, Ngeow YF, Yap SF, Tay ST. Evaluation of PCR-RFLP analysis targeting hsp65 and rpoB genes for the typing of mycobacterial isolates in Malaysia. J Med Microbiol. 2010;59(Pt 11):1311–1316. doi:10.1099/jmm.0.021139-0